Why hire Metro Infectious Disease Consultants for your skilled nursing facility?

Metro Infectious Disease Consultants partners with skilled nursing facilities to provide a comprehensive infectious disease management program.

Metro Infectious Disease Consultants has been a leader in providing infectious disease services for skilled nursing facilities in the Chicagoland area for many years.

We help facilities with all matters related to infection control and prevention, including antibiotic stewardship, isolation management, and outbreak management.

For Long-Term Care Facilities you can expect:

  • Reduce medication costs
  • Reduce the number of patients in isolation
  • Reduce hospital readmissions and transfers
  • Save on average $65,000–$100,000 annually
  • Minimize management time expenditure
  • Avoid CMS and other regulatory agency violations

Metro Infectious Disease Consultants Skilled Nursing Program Highlights

Skilled Nursing Program Highlights

Antibiotic Stewardship

Overuse of antibiotics is costly and leads to antibiotic resistance, a primary concern for hospitals, long-term care facilities, and patients.

Appropriately utilizing antibiotics is a critical component of patient care in the long-term care facility where significant cost savings can be achieved.

Metro Infectious Disease Consultants offers a full-service Antibiotic Stewardship Program to help any facility achieve Joint Commission and CMS compliance and realize all the clinical and economic benefits associated.

Isolation Management

While there certainly are times residents need to be isolated – such as for an active MRSA infection, or an uncontained draining wound – far more often, isolation is not warranted and is detrimental. Skilled nursing facilities are often caring for very sick patients.

Metro Infectious Disease Consultants has comprehensive protocols in place to ensure that the appropriate patients are isolated.

Releasing residents from unnecessary isolation not only saves money but can have a substantial effect on a patient’s quality of life.

Metro Infectious Disease Consultants physicians will provide ongoing education to staff regarding isolation guidelines and are on call 24/7 to help answer any questions that arise when we are not present at the building.

Outbreak Management

Metro Infectious Disease Consultants physicians are experts in outbreak management. Common outbreaks seen in long term care facilities are influenza, norovirus, and scabies. When an outbreak is suspected, our physician will oversee the outbreak from beginning to end. We manage all hospital transfers, which limits patient visits to the ER. This is extremely beneficial to both the facility and the patient.

Pre-admission Consulting

One very unique aspect of the Metro Infectious Disease Consultants long term care infectious disease program is pre-admission consulting. If a patient is going to be admitted to the facility while on antibiotics, Metro Infectious Disease Consultants can consult on the case to see whether the costly antibiotic is absolutely necessary or if it can be switched to a lower-cost therapeutic alternative.

We are available to our partner facilities 24/7 and can help provide clarity and cost savings before the patient arrives at the building.

Ongoing Clinical Education

Metro Infectious Disease Consultants is happy to provide ongoing clinical education to staff, patients, and family members. We offer periodic educational seminars covering the most critical clinical issues faced in extended care facilities and are available for educational programming at the request of the facility administrator.

Telemedicine

We now offer a telemedicine option for facilities that are outside of our practice boundaries. Our physicians can manage infectious disease services remotely, which is an excellent option for extended care facilities that do not have access to infectious disease specialists in their area.

If you would like to speak with us about ID services for your facility, please email swu@midcusa.com

Our Skilled Nursing Program Team

Metro Infectious Disease Consultants physicians and pharmacists are both practice and thought leaders in infectious disease management. We speak widely at medical conferences and regularly contribute to scientific and business literature.

Russell Petrak, MD

Managing Partner, Metro Infectious Disease Consultants
Managing Partner and CEO, Innovative Ventures, a management services organization

Russell M. Petrak is a board-certified infectious disease specialist practicing in the Chicago area. He is one of the founding members and managing partner of Metro Infectious Disease Consultants, L.L.C. (MIDC), a 100 member fully integrated ID group servicing 100 hospitals and 20 offices. Founded in 1994, MIDC provides comprehensive infectious disease services including inpatient and outpatient consultation, traveler’s immunizations, and outpatient antibiotic therapy throughout Northern Illinois, Indiana, Iowa, and Michigan.

Dr. Petrak was trained at Rush Medical College and completed his internship, residency, and fellowship in infectious disease at Rush-Presbyterian-St. Luke’s Medical Center in Chicago. His first six years of practice were spent as teaching faculty at a Westside Chicago hospital before being appointed Academic Director of Medicine. As such, he served as program director for several residency programs, and directly supervised the subspecialty departments of internal medicine.

In 1997, he became a member of the Clinical Affairs Committee of IDSA and served as Chairman from 2000-2003. He remains an active member of the IDSA Outpatient Parenteral Antimicrobial Therapy Task Force, and was recently the lead author of an article entitled “The Value of an Infectious Disease Specialist.”

For the past 12 years, Dr. Petrak has been invited to speak at the annual IDSA Fellows Meeting, where he has lectured on topics such as, “How to Interview for an ID Job,” and “The Art and Science of Infectious Diseases Consultation”.

Nick Van Hise, PharmD, BCPS

Infectious Disease Clinical Pharmacy Specialist

Duties: Antibiotic stewardship team lead, research coordinator

Board Certification: Infectious Disease and Pharmacotherapy

Training:  Infectious Disease Training at Indiana University Health AHC, Pharmacotherapy at Mercy Hospital, St. Louis, Doctor of Pharmacy at Union University School of Pharmacy, Bachelors of Science at Bradley University

Anjum Owaisi, MD

Infectious Disease Physician

Duties: Physician Lead of Outpatient Antibiotic Stewardship; practicing infectious disease provider

Board Certification: Infectious Disease and Internal Medicine

Training: Medical School, Rush Medical Center; Internal Medicine, and Infectious Disease, Northwestern University; Infectious Disease Fellowship, Rush University Medical Center

Brian Harting, MD

Infectious Disease Physician

Duties: Physician Lead of Inpatient Antibiotic Stewardship; Physician Lead of Outpatient Antibiotic Stewardship

Board Certification: Infectious Disease and Internal Medicine

Training: Medical School, St Louis University; Internal Medicine, and Infectious Disease, Rush University Medical Center; Infectious Disease Fellowship, Rush University Medical Center

Ram Ramani, MD

Infectious Disease Physician

Duties: Physician Co-Lead of Inpatient Antibiotic Stewardship; Physician Lead of Outpatient Antibiotic Stewardship

Board Certification: Infectious Disease and Internal Medicine

Training: Medical School, Osmania University Medical Center; Internal Medicine, and Infectious Disease, University of Illinois; Infectious Disease Fellowship, University of Illinois Medical Center

Publications

Petrak, R.M., Fliegelman, R.M., and Hines, D.W. The Art and Science of Infectious Diseases Consultation. Infectious Diseases in Clinical Practice 2008;16:147-153.

Daniel P. McQuillen, M.D., Russell M. Petrak, M.D., Ronald B. Wasserman, M.D., Ronald G. Nahass, M.D., Jason A. Scull, and Lawrence P. Martinelli, M.D. The Value of Infectious Diseases Specialists—Non-Patient Care Activities. CID 2008:47:1051-62.

Effectiveness of Chlorhexidine Bathing to Reduce Catheter-Associated Bloodstream Infections in Medical Intensive Care Unit Patients. Archives of Internal Medicine 2007; 167 (19): 2073-9.

Steven Schmitt, Daniel P. McQuillen, Ronald Nahass, Lawrence Martinelli, Michael Rubin, Kay Schwebke, Russell Petrak, J. Trees Ritter, David Chansolme, Thomas Slama, Edward M. Drozd, Shamonda F. Braithwaite, Michael Johnsrud, Eric Hammelman. Infectious Diseases Specialty Intervention Is Associated With Decreased Mortality and Lower Healthcare Costs. CID 2014:58:22-28.

Van Hise, et al. Efficacy of Oral Vancomycin in Prevent Recurrent Clostridium difficile Infection in Patients Treated with Systemic Antimicrobial Agents. Clinical Infectious Diseases 2016. Doi: 10.1093/cid/ciw401.

Van Hise, et al. Reply to Cheng et al. Clinical Infectious Diseases 2016.

Van Hise, NW, Petrak RM. Clinical Infectious Diseases. Use of long-acting lipoglycopeptides for acute osteomyelitis

Slama, T.G., Sexton, D.J., Ingram, C.W., Petrak, R.M., and Joseph, W.P.: Findings of the 1998 Infectious Diseases Society of America Membership Survey. Clinical Infectious Diseases, 2000;31:1396-402.

Tenenbaum, M.J. and Petrak, R. M. Business Aspects of Infectious Diseases. Clinical Infectious Diseases, 2002:34:420.

Petrak, R.M., Sexton, D.J., Butera, M.L., Tenenbaum, M.J., MacGregor, M.C., Schmidt, M.E., Joseph, W.P., Kemmerly, S.A., Dougherty, M.J., Bakken, J.S., Curfman, M.F., Martinelli, LP., and

Gainer, R.B. Clinical Practice: The Value of an Infectious Disease Specialist. CID: 2003;36:1013-17.